Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Neurological Sciences

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0022-510X(99)00298-1PMID 10675577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibodies against viruses and structural brain components in oligoclonal IgG obtained from multiple sclerosis brain

  2004cited by this paper
• Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis

  1998cited by this paper
• Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.

  1997cited by this paper
• The implications of Epstein‐Barr virus in multiple‘ sclerosis ‐ a review

  1997cited by this paper
• Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy.

  1997cited by this paper
• The detection of intrathecal synthesis of anti‐herpes simplex IgG antibodies: Comparison between an antigen‐mediated immunoblotting technique and antibody index calculations

  1997cited by this paper
• An Epstein Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway.

  1996cited by this paper
• Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study

  1995cited by this paper
• [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].

  1995cited by this paper
• Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

  1994cited by this paper
• Quantitation of intrathecal measles virus IgG antibody synthesis rate: subacute sclerosing panencephalitis and multiple sclerosis.

  1994cited by this paper
• Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation.

  1994cited by this paper
• Symptomatic Epstein-Barr virus infection and multiple sclerosis.

  1993cited by this paper
• Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSG and two pentapepfide seauence identities between EBNA A and myelin basic protein

  1992cited by this paper
• Western blotting analysis in patients with MS using human brain vessels as antigen

  1992cited by this paper
• Demyelinating disease after neurologically complicated primary Epstein‐Barr virus infection

  1992cited by this paper
• Intrathecal immunoglobulin synthesis: Comparison of various formulae with the ‘gold standard’ of isoelectric focusing

  1991cited by this paper
• Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway.

  1991cited by this paper
• Diagnostic usefulness of cerebrospinal fluid in multiple sclerosis.

  1991cited by this paper
• Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain.

  1991cited by this paper
• Searching for peptide ligands with an epitope library.

  1990cited by this paper
• Immunological differentiation between neuroborreliosis and multiple sclerosis

  1990cited by this paper
• Isoelectric Focusing of Cerebrospinal Fluid Immunoglobulin G: An Annotated Update

  1990cited by this paper
• Intrathecal synthesis of virus-specific oligoclonal antibodies in patients with enterovirus infection of the central nervous system

  1989cited by this paper
• A case‐control study of multiple sclerosis

  1989cited by this paper
• An isoelectric focusing study in herpes simplex virus encephalitis

  1988cited by this paper
• Immunoblot detection of oligoclonal anti‐myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis

  1987cited by this paper
• The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1).

  1987cited by this paper
• Epstein‐Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis

  1985cited by this paper
• Immunoglobulin G, A, and M--clonal restriction in multiple sclerosis cerebrospinal fluid and serum--analysis by two-dimensional electrophoresis.

  1985cited by this paper
• Increased prevalence and titer of Epstein‐Barr virus antibodies in patients with multiple sclerosis

  1985cited by this paper
• Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis.

  1983cited by this paper
• Production and characterization of monoclonal antibodies to bovine immunoglobulin G2.

  1982cited by this paper
• Epstein-Barr virus antibodies in multiple sclerosis.

  1980cited by this paper
• Viral and bacterial antibody responses in multiple sclerosis

  1980cited by this paper
• Viral antibodies in multiple sclerosis.

  1978cited by this paper
• Handbook of experimental immunology

  1967cited by this paper
• PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

  1965cited by this paper

• Epstein-barr virus and multiple sclerosis: from pathogenesis and diagnosis to EBV-specific T cell therapy and gene-targeted therapeutics.

  2026cites this paper
• The Life and Works of Dr. Kenneth M. Heilman.

  2025cites this paper
• Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

  2024cites this paper
• Herpesviridae, Neurodegenerative Disorders and Autoimmune Diseases: What Is the Relationship between Them?

  2024cites this paper
• Broad Analysis of Serum and Intrathecal Antimicrobial Antibodies in Multiple Sclerosis Underscores Unique Role of Epstein-Barr Virus

  2024cites this paper
• How to and should we target EBV in MS?

  2024cites this paper
• Antibody Content against Epstein–Barr Virus in Blood Extracellular Vesicles Correlates with Disease Activity and Brain Volume in Patients with Relapsing–Remitting Multiple Sclerosis

  2023cites this paper
• Antibodies to expanded virus antigen panels show elevated diagnostic sensitivities in multiple sclerosis and optic neuritis.

  2023cites this paper
• Oligoclonal bands: An immunological and clinical approach.

  2022cites this paper
• The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis

  2021cites this paper
• Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis

  2021cites this paper
• Evaluating the Role of HLA DRB1 Alleles and Oligoclonal Bands in Influencing Clinical Course of Multiple Sclerosis – A Study from the Mangalore Demyelinating Disease Registry

  2021influential citation
• Herpesviruses and the hidden links to Multiple Sclerosis neuropathology.

  2021cites this paper
• Viral infections and multiple sclerosis

  2020cites this paper
• The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review

  2020cites this paper
• Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands

  2020cites this paper
• B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers

  2020cites this paper
• The role of infections in multiple sclerosis

  2019cites this paper
• Low intrathecal antibody production despite high seroprevalence of Epstein–Barr virus in multiple sclerosis: a review of the literature

  2018cites this paper
• Recognition of Epstein-Barr Virus in Multiple Sclerosis

  2018cites this paper
• Factores clínicos, ambientales y genéticos implicados en la respuesta al tratamiento con fingolimod en pacientes con esclerosis múltiple

  2017cites this paper
• Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barré syndrome

  2017influential citation
• A Commentary on the Use of Epstein-Barr Virus Specific Antibodies as Biological Markers in Multiple Sclerosis

  2017influential citation
• Factors promoting B cell activation and accumulation in the inflamed CNS

  2017cites this paper
• Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention—An Update

  2016cites this paper
• Intrathecal Immunoglobulin Synthesis in MS—A Complete Reappraisal

  2016cites this paper
• Human herpesvirus 6, Varicella-Zoster virus and oligoclonal bands in demyelinating diseases of the central nervous system

  2016cites this paper
• Antigen-Specific Binding of Multivalent Soluble Antigen Arrays Induces Receptor Clustering and Impedes B Cell Receptor Mediated Signaling.

  2016cites this paper
• A Review of Multiple Sclerosis as an Infectious Syndrome

  2016cites this paper
• Investigating the role of Epstein-Barr virus in the pathogenesis of Multiple Sclerosis

  2015cites this paper
• Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein–Barr virus infection

  2015cites this paper
• The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.

  2015cites this paper
• EBV-Associated Cancer and Autoimmunity: Searching for Therapies

  2015cites this paper
• The influence of common infections on clinical course and neurodegeneration in an animal model of multiple sclerosis

  2015cites this paper
• Association of multiple sclerosis with Epstein-Barr virus infection.

  2015cites this paper
• Infections and multiple sclerosis

  2014influential citation
• HLA-DRB1 15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer.

  2014influential citation
• Multiple Sclerosis and Microbes

  2014cites this paper
• Polymorphisms in interleukin-2 and interleukin-7 receptor α-chain genes and Human herpes virus-6 as risk factors for multiple sclerosis.

  2014cites this paper
• Acute disseminated encephalomyelitis progressing to multiple sclerosis: Are infectious triggers involved?

  2014cites this paper
• Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies

  2014influential citation
• Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy

  2014cites this paper
• Environmental risk factors for multiple sclerosis

  2013cites this paper
• ANTI-DRUG ANTIBODIES IN PATIENTS WITH MULTIPLE SCLEROSIS

  2013influential citation
• Multiple Sklerose und Epstein-Barr-Virus: Eine aktuelle Übersicht

  2013cites this paper
• Risk Factors in Cause and Course of Multiple Sclerosis

  2012cites this paper
• Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis

  2011cites this paper
• Development of anti-CD20 therapy for multiple sclerosis.

  2011cites this paper
• The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis

  2011cites this paper
• Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases.

  2011cites this paper
• Environmental Risk Factors for Paediatric Multiple Sclerosis

  2011cites this paper
• Epstein–Barr virus and multiple sclerosis

  2011cites this paper
• Das lymphozytäre Entzündungsinfiltrat in Multiple-Sklerose-Läsionen: Immunhistochemische Analyse im Bezug auf immunopathogenetische Subtypen und Läsionsaktivitäten

  2011cites this paper
• Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis

  2010cites this paper
• Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis

  2010cites this paper
• 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Epstein–Barr virus and multiple sclerosis: epidemiological evidence

  2010cites this paper
• Epstein–Barr Virus Infection and Multiple Sclerosis: A Review

  2010cites this paper
• No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.

  2010cites this paper
• Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain: Implications for Viral Persistence and Intrathecal B-Cell Activation

  2010cites this paper
• Epidemiological analysis of viral infections as risk factors for multiple sclerosis

  2009influential citation
• Human herpesvirus 6 in multiple sclerosis and encephalitis

  2009cites this paper
• Epstein-Barr virus and multiple sclerosis.

  2009cites this paper
• Multiplexing approaches for autoantibody profiling in multiple sclerosis.

  2009cites this paper
• Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis

  2009cites this paper
• Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI

  2009cites this paper
• A population-based case–control study on viral infections and vaccinations and subsequent multiple sclerosis risk

  2009cites this paper
• Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.

  2009cites this paper
• An overview of gene-epigenetic-environmental contributions to MS causation.

  2009cites this paper
• Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis

  2008cites this paper
• Herpesviruses and autoimmunity.

  2008cites this paper
• Could Epstein-Barr virus or canine distemper virus cause multiple sclerosis?

  2008cites this paper
• Risk factors in the development of multiple sclerosis

  2007cites this paper
• Multiple sclerosis: the environment and causation

  2007cites this paper
• Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

  2007cites this paper
• Human herpesviruses in MS.

  2007cites this paper
• Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

  2007cites this paper
• Environmental risk factors for multiple sclerosis. Part I: The role of infection

  2007cites this paper
• [Infection by Epstein-Barr virus and multiple sclerosis].

  2006cites this paper
• The role of EBV in MS pathogenesis.

  2006cites this paper
• Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae.

  2006cites this paper
• Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis

  2006cites this paper
• Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.

  2006cites this paper
• Multiple sclerosis is linked to Epstein‐Barr virus infection

  2006influential citation
• POSSIBLE MECHANISMS BY WHICH EBV INFECTION COULD PROMOTE AUTOIMMUNE DISEASE

  2005cites this paper
• Epstein-Barr Virus and Autoimmunity

  2004cites this paper
• Role of viruses in etiology and pathogenesis of multiple sclerosis

  2004cites this paper
• Godište : 14 INFLAMMATION AND HUMORAL IMMUNE RESPONSE WITHIN THE CNS COMPARTMENT : CHARACTERISTIC FEATURES AND CEREBROSPINAL FLUID ANALYSIS

  2004cites this paper
• Epstein-Barr Virus and the Nervous System

  2003cites this paper
• Multiple sclerosis in Västerbotten county, northern Sweden

  2003cites this paper
• Multiple Sclerosis and Human Herpesvirus 6

  2002cites this paper
• Viruses and Multiple Sclerosis

  2000cites this paper